Literature DB >> 11032850

Escort aptamers: a delivery service for diagnosis and therapy.

B J Hicke1, A W Stephens.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11032850      PMCID： PMC314349          DOI： 10.1172/JCI11324

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  29 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

3.  A SELEX primer.

Authors:  T Fitzwater; B Polisky
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

Review 4.  Small peptides radiolabeled with 99mTc.

Authors:  J Lister-James; B R Moyer; T Dean
Journal:  Q J Nucl Med       Date:  1996-09

5.  Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo.

Authors:  S R Watson; Y F Chang; D O'Connell; L Weigand; S Ringquist; D H Parma
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-04

Review 6.  Diversity of oligonucleotide functions.

Authors:  L Gold; B Polisky; O Uhlenbeck; M Yarus
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 7.  Oligonucleotides as research, diagnostic, and therapeutic agents.

Authors:  L Gold
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

Review 8.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 9.  Clinical radioimmunotherapy.

Authors:  S J Knox; R F Meredith
Journal:  Semin Radiat Oncol       Date:  2000-04       Impact factor: 5.934

10.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.

Authors:  W A Pieken; D B Olsen; F Benseler; H Aurup; F Eckstein
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728
View more
  41 in total

Review 1.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 3.  Cellular and molecular basis of inflammatory myocardial disease.

Authors:  W H Barry
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

4.  Aptamares: a novel class of radiopharmaceutical with diagnostic and therapeutic potential.

Authors:  S Guhlke; M Famulok; H J Biersack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11       Impact factor: 9.236

Review 5.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 6.  Nucleic acid aptamers: clinical applications and promising new horizons.

Authors:  X Ni; M Castanares; A Mukherjee; S E Lupold
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 7.  Drug delivery systems in urology--getting "smarter".

Authors:  Omid C Farokhzad; Jordan D Dimitrakov; Jeffrey M Karp; Ali Khademhosseini; Michael R Freeman; Robert Langer
Journal:  Urology       Date:  2006-09       Impact factor: 2.649

8.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Authors:  Raphaël Boisgard; Bertrand Kuhnast; Stefan Vonhoff; Chéraz Younes; Françoise Hinnen; Jean-Marc Verbavatz; Bernard Rousseau; Jens Peter Fürste; Britta Wlotzka; Frédéric Dollé; Sven Klussmann; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-22       Impact factor: 9.236

Review 9.  Efficient siRNA delivery with non-viral polymeric vehicles.

Authors:  Won Jong Kim; Sung Wan Kim
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

10.  Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.

Authors:  Jiehua Zhou; Piotr Swiderski; Haitang Li; Jane Zhang; C Preston Neff; Ramesh Akkina; John J Rossi
Journal:  Nucleic Acids Res       Date:  2009-03-21       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.